We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
-12.85%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+549.41%
AUM
$323B
AUM Growth
-$31.4B
Cap. Flow
+$21.9B
Cap. Flow %
6.78%
Top 10 Hldgs %
17.35%
Holding
4,266
New
149
Increased
3,108
Reduced
374
Closed
120

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$1.01B
2
MSFT icon
Microsoft
MSFT
+$761M
3
AAPL icon
Apple
AAPL
+$685M
4
AMZN icon
Amazon
AMZN
+$507M
5
CI icon
Cigna
CI
+$391M

Sector Composition

Rank Sector Weight
1 Technology 17.64%
2 Financials 15.19%
3 Healthcare 14.85%
4 Consumer Discretionary 10.09%
5 Industrials 9.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RDHL
3876
Redhill Biopharma
RDHL
$3.89M
$73K ﹤0.01%
+13
New +$99.6K
SGRP
3877
DELISTED
SPAR Group
SGRP
$73K ﹤0.01%
145,742
TARA icon
3878
Protara Therapeutics
TARA
$224M
$73K ﹤0.01%
809
NAVB
3879
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$73K ﹤0.01%
36,010
TMBR
3880
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
$72K ﹤0.01%
45
LWAY icon
3881
Lifeway Foods
LWAY
$454M
$71K ﹤0.01%
38,028
NDRA icon
3882
ENDRA Life Sciences
NDRA
$5.84M
$71K ﹤0.01%
+1
New +$116K
FOMX
3883
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$71K ﹤0.01%
19,970
NVLN
3884
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$71K ﹤0.01%
82,901
+26,003
+46% +$29.4K
CODX
3885
Co-Diagnostics
CODX
$5.09M
$70K ﹤0.01%
1,610
EVER icon
3886
EverQuote
EVER
$836M
$70K ﹤0.01%
+16,851
New +$156K
REPX icon
3887
Riley Exploration Permian
REPX
$731M
$70K ﹤0.01%
6,190
GVP
3888
DELISTED
GSE Systems, Inc.
GVP
$70K ﹤0.01%
3,354
IMI
3889
DELISTED
Intermolecular, Inc.
IMI
$70K ﹤0.01%
69,386
ADIL
3890
Adial Pharmaceuticals
ADIL
$9.78M
$69K ﹤0.01%
+22
New +$35.2K
AQB icon
3891
AquaBounty Technologies
AQB
$6.07M
$69K ﹤0.01%
1,689
FLL icon
3892
Full House Resorts
FLL
$80.9M
$69K ﹤0.01%
34,413
MSN icon
3893
Emerson Radio
MSN
$7.79M
$69K ﹤0.01%
48,121
MYO icon
3894
Myomo
MYO
$51.8M
$69K ﹤0.01%
1,612
RADA
3895
DELISTED
Rada Electronic Industries Ltd
RADA
$68K ﹤0.01%
26,723
NBRV
3896
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$68K ﹤0.01%
187
PAVM icon
3897
PAVmed
PAVM
$37.2M
$67K ﹤0.01%
157
VIRX
3898
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$67K ﹤0.01%
4,654
EMAN
3899
DELISTED
eMagin Corporation
EMAN
$67K ﹤0.01%
65,621
MRIN
3900
DELISTED
Marin Software
MRIN
$66K ﹤0.01%
2,074

Similar funds

Geode Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, Geode Capital Management held 4,266 positions worth $323B, down 8.8% from $355B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Geode Capital Management deployed $21.9B of net new capital in Q4 2018, opening 149 new positions and adding to 3,108 existing holdings. Its largest new stake was Linde: 6,406,340 shares worth $998M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Dell, an estimated $92.5M trimmed.

  • Geode Capital Management's largest Q4 2018 buy was Linde: 6,406,340 shares worth $998M.
  • Geode Capital Management added most to Microsoft in Q4 2018, an estimated $761M increase.
  • Geode Capital Management's biggest Q4 2018 reduction was Dell, cutting an estimated $92.5M.
  • Geode Capital Management fully exited Aetna Inc in Q4 2018, selling an estimated $741M.
  • Geode Capital Management's ten largest holdings make up 17% of its $323B portfolio in Q4 2018.
  • Geode Capital Management opened 149 new positions and closed 120 in Q4 2018.
  • Geode Capital Management's portfolio value fell 8.8% quarter-over-quarter to $323B.

Based on Geode Capital Management's 13F filing for Q4 2018, filed 13 Feb 2019.